Expert Pitch

FDA to Decide on Alzheimer's Drug Approval - During National Alzheimer’s & Brain Awareness Month

Hackensack Meridian Health

It is estimated that someone in America will develop Alzheimer's disease every 67 seconds. As many as 500,000 new cases of Alzheimer's disease are expected to be diagnosed this year.

With no known cure, the Food & Drug Administration is anticipated to make a historic decision Monday, June 7 on whether to approve the first-ever treatment for mild cognitive decline and early-stage dementia caused by Alzheimer’s. 

The drug called Aducanumab is said to work by binding to the plaques between neurons and causing an immune response that removes them.

“That plaque is what is believed to gum up the brain in people who have the disease, so the long-held ‘amyloid theory’ suggests that if the plaque can be cleared away, cognition could improve, or at the very least, decline more slowly,” explained Manisha Parulekar, M.D., director, Division of Geriatrics, Hackensack Meridian Hackensack University Medical Center.

“Regardless of the FDA’s final decision, this is an important moment as we have never before been this close to approval of a medication for Alzheimer’s that could change the progression of the disease, not just the symptoms,” says Dr. Gary Small, chair of Psychiatry at Hackensack Meridian Health. 

Both Dr. Parulekar and Dr. Small can be available for comment. I can also get you in touch with the family of an Alzheimer's patient who is happy to share their story.

Mary McGeever, PR Manager, Hackensack University Medical Center

 

Filters close

Showing results

110 of 6046
access_time Embargo lifts in 2 days
Embargo will expire: 26-Jul-2021 12:15 AM EDT Released to reporters: 22-Jul-2021 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2021 12:15 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Jul-2021 4:30 PM EDT
Small-Scale Worker Resistance Impacts Food Delivery Economy in China
Cornell University

Research from Cornell University has revealed a new form of bargaining power among Chinese platform-based food delivery workers, who conduct invisible mini-strikes by logging out of apps and airing grievances over.

Released: 15-Jul-2021 1:10 PM EDT
Even on Facebook, COVID-19 Polarized Members of U.S. Congress
Ohio State University

Facebook posts by members of the U.S. Congress reveal the depth of the partisan divide over the COVID-19 pandemic, new research shows.

Released: 13-Jul-2021 5:05 PM EDT
Patients in Michigan Gain Increased Access to Affordable, Quality Anesthesia Care
American Association of Nurse Anesthetists (AANA)

Michigan patients now have increased access to safe, affordable care with the signing of HB 4359 by Governor Gretchen Whitmer. The law removes supervision requirements for nurse anesthetists and grants them the authority to collaboratively participate in a patient-centered healthcare team.

Released: 13-Jul-2021 4:30 PM EDT
US citizen migrant children in Mexico lacking adequate health insurance
University of Houston

While attending a conference at the Universidad Nacional Autónoma de México in Mexico City several years ago, Sharon Borja was struck by the story of a young man who, as a child, joined his parents repatriating to their native country of Mexico.

Newswise: California Makes Historic Investment in HSU’s Polytechnic Plans
Released: 13-Jul-2021 3:25 PM EDT
California Makes Historic Investment in HSU’s Polytechnic Plans
Humboldt State University

California Governor Gavin Newsom and the State Legislature have agreed on a new state budget with a historic $458 million investment in Humboldt State University’s effort to become Northern California’s first polytechnic institution.

Newswise: Allocating COVID-19 vaccines based on health and socioeconomic factors could reduce mortality
8-Jul-2021 11:30 AM EDT
Allocating COVID-19 vaccines based on health and socioeconomic factors could reduce mortality
PLOS

Study suggests spatial relationship between COVID-19 mortality and population-level health factors.


Showing results

110 of 6046

close
2.1729